Inactive Ingredient Search for Approved Drug Products
Search Names Beginning with 0-9
| Inactive Ingredient | Route | Dosage Form | CAS Number | UNII | Maximum Potency per unit dose | Maximum Daily Exposure (MDE) | Record Updated |
|---|---|---|---|---|---|---|---|
| 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE | INTRAVENOUS | INJECTABLE, LIPOSOMAL | 816944 | 043IPI2M0K | 2.8%w/v | ||
| 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE | INTRAVENOUS | INJECTION | 816944 | 043IPI2M0K | 68mg | ||
| 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE | RESPIRATORY (INHALATION) | CAPSULE | 816944 | 043IPI2M0K | 51mg | ||
| 2-(4-STYRYL-3-SULFOPHENOL)-6-METHOXYBENZOTRIAZOLE | TOPICAL | SOAP | 1333659 | 0MMD46SPU6 | 0.75%w/w | ||
| ACRYL-EZE 93018509 WHITE | ORAL | TABLET | NA | 153mg | |||
| ACRYL-EZE 93018509 WHITE | ORAL | TABLET, EXTENDED RELEASE | NA | 48mg | |||
| ACRYL-EZE 93084720 PINK | ORAL | TABLET, DELAYED RELEASE | NA | 234mg | |||
| ADCOTE 72A103 | TRANSDERMAL | SYSTEM | NA | 16mg | |||
| BUTYL METHACRYLATE AND METHYL METHACRYLATE COPOLYMER (3:1; 150000 MW) | TRANSDERMAL | SYSTEM | 25608337 | DJN2FGG8Z3 | 18mg | ||
| C13-14 ISOPARAFFIN/LAURETH-7/POLYACRYLAMIDE | TOPICAL | GEL | NA | 5%w/w | |||
| CELLULOSE ACETATE CA-320S | ORAL | TABLET, EXTENDED RELEASE | NA | 143mg | |||
| CELLULOSE ACETATE CA-398-10 | ORAL | TABLET, EXTENDED RELEASE | NA | 113mg | |||
| CETEARETH-30 | TOPICAL | CREAM | 68439496 | 1R9DCZ5FOX | 3%w/w | ||
| CETEARETH-30 | TOPICAL | CREAM, AUGMENTED | 68439496 | 1R9DCZ5FOX | 1%w/w | ||
| CETEARETH-30 | TOPICAL | LOTION | 68439496 | 1R9DCZ5FOX | 2.3%w/w | ||
| CETETH-23 | TOPICAL | CREAM | 9004959 | 495CTZ441V | 2%w/w | ||
| COPOVIDONE K25-31 | ORAL | CAPSULE | 25086899 | D9C330MD8B | 1346mg | ||
| COPOVIDONE K25-31 | ORAL | CAPSULE, COATED PELLETS | 25086899 | D9C330MD8B | 88mg | ||
| COPOVIDONE K25-31 | ORAL | CAPSULE, DELAYED RELEASE | 25086899 | D9C330MD8B | 199mg | ||
| COPOVIDONE K25-31 | ORAL | CAPSULE, EXTENDED RELEASE | 25086899 | D9C330MD8B | 200mg | ||
| COPOVIDONE K25-31 | ORAL | PELLET | 25086899 | D9C330MD8B | 1653mg | ||
| COPOVIDONE K25-31 | ORAL | POWDER, FOR SUSPENSION | 25086899 | D9C330MD8B | 5917mg | ||
| COPOVIDONE K25-31 | ORAL | SUSPENSION | 25086899 | D9C330MD8B | 172mg | ||
| COPOVIDONE K25-31 | ORAL | TABLET | 25086899 | D9C330MD8B | 6374mg | ||
| COPOVIDONE K25-31 | ORAL | TABLET, CHEWABLE | 25086899 | D9C330MD8B | 5mg | ||
| COPOVIDONE K25-31 | ORAL | TABLET, DELAYED RELEASE | 25086899 | D9C330MD8B | 168mg | ||
| COPOVIDONE K25-31 | ORAL | TABLET, EXTENDED RELEASE | 25086899 | D9C330MD8B | 300mg | ||
| COPOVIDONE K25-31 | ORAL | TABLET, FILM COATED | 25086899 | D9C330MD8B | 5917mg | ||
| COPOVIDONE K25-31 | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 25086899 | D9C330MD8B | 53mg | ||
| COPOVIDONE K25-31 | ORAL | TABLET, ORALLY DISINTEGRATING | 25086899 | D9C330MD8B | 4.38mg | ||
| COPOVIDONE K25-31 | SUBLINGUAL | TABLET | 25086899 | D9C330MD8B | 54mg | ||
| COPOVIDONE K25-31 | TRANSDERMAL | FILM, EXTENDED RELEASE | 25086899 | D9C330MD8B | NA | ||
| D&C GREEN NO. 3 LAKE | ORAL | CAPSULE | NA | NA | |||
| D&C GREEN NO. 3 LAKE | ORAL | TABLET, COATED | NA | NA | |||
| D&C RED NO. 30 | ORAL | CAPSULE | 52641313 | 2S42T2808B | 0.1mg | ||
| D&C RED NO. 30 | ORAL | TABLET | 52641313 | 2S42T2808B | 19mg | ||
| D&C RED NO. 30 | ORAL | TABLET, CHEWABLE | 52641313 | 2S42T2808B | 3mg | ||
| D&C RED NO. 30 | ORAL | TABLET, CHEWABLE, EXTENDED RELEASE | 52641313 | 2S42T2808B | 1mg | ||
| D&C RED NO. 30 | ORAL | TABLET, COATED | 52641313 | 2S42T2808B | 1.16mg | ||
| D&C RED NO. 30 | ORAL | TABLET, DELAYED RELEASE | 52641313 | 2S42T2808B | NA | ||
| D&C RED NO. 30 | ORAL | TABLET, EXTENDED RELEASE | 52641313 | 2S42T2808B | 0.22mg | ||
| D&C RED NO. 30 | ORAL | TABLET, FILM COATED | 52641313 | 2S42T2808B | 0.26mg | ||
| D&C RED NO. 30 ALUMINUM LAKE | ORAL | CAPSULE | NA | NA | |||
| D&C RED NO. 30 ALUMINUM LAKE | ORAL | CAPSULE, DELAYED RELEASE | NA | 0.3mg | |||
| D&C RED NO. 30 ALUMINUM LAKE | ORAL | POWDER, FOR SUSPENSION | NA | 18mg | |||
| D&C RED NO. 30 ALUMINUM LAKE | ORAL | SUSPENSION | NA | 1mg | |||
| D&C RED NO. 30 ALUMINUM LAKE | ORAL | SUSPENSION, EXTENDED RELEASE | NA | 7mg | |||
| D&C RED NO. 30 ALUMINUM LAKE | ORAL | TABLET | NA | 30mg | |||
| D&C RED NO. 30 ALUMINUM LAKE | ORAL | TABLET, CHEWABLE | NA | 5mg | |||
| D&C RED NO. 30 ALUMINUM LAKE | ORAL | TABLET, COATED | NA | 5mg | |||
| D&C RED NO. 30 ALUMINUM LAKE | ORAL | TABLET, DELAYED RELEASE | NA | 0.04mg | |||
| D&C RED NO. 30 ALUMINUM LAKE | ORAL | TABLET, EXTENDED RELEASE | NA | 0.1mg | |||
| D&C RED NO. 30 ALUMINUM LAKE | ORAL | TABLET, FILM COATED | NA | 0.3mg | |||
| D&C RED NO. 30 ALUMINUM LAKE | ORAL | WAFER | NA | 0.9mg | |||
| D&C RED NO. 33 | DENTAL | SOLUTION | 3567666 | 9DBA0SBB0L | NA | ||
| D&C RED NO. 33 | ORAL | CAPSULE | 3567666 | 9DBA0SBB0L | 1mg | ||
| D&C RED NO. 33 | ORAL | CAPSULE, EXTENDED RELEASE | 3567666 | 9DBA0SBB0L | NA | ||
| D&C RED NO. 33 | ORAL | CAPSULE, LIQUID FILLED | 3567666 | 9DBA0SBB0L | 0.01mg | ||
| D&C RED NO. 33 | ORAL | CONCENTRATE | 3567666 | 9DBA0SBB0L | 0.02mg/1ml | ||
| D&C RED NO. 33 | ORAL | ELIXIR | 3567666 | 9DBA0SBB0L | 27.5mg/5ml | ||
| D&C RED NO. 33 | ORAL | SOLUTION | 3567666 | 9DBA0SBB0L | 2mg | ||
| D&C RED NO. 33 | ORAL | SUSPENSION | 3567666 | 9DBA0SBB0L | 0.13mg/5ml | ||
| D&C RED NO. 33 | ORAL | SUSPENSION, EXTENDED RELEASE | 3567666 | 9DBA0SBB0L | NA | ||
| D&C RED NO. 33 | ORAL | SYRUP | 3567666 | 9DBA0SBB0L | 0.1mg | ||
| D&C RED NO. 33 | ORAL | TABLET | 3567666 | 9DBA0SBB0L | 0.24mg | ||
| D&C RED NO. 33 | ORAL | TABLET, COATED | 3567666 | 9DBA0SBB0L | NA | ||
| D&C RED NO. 33 | ORAL | TABLET, FILM COATED | 3567666 | 9DBA0SBB0L | NA | ||
| D&C RED NO. 33 | TOPICAL | SHAMPOO | 3567666 | 9DBA0SBB0L | NA | ||
| D&C RED NO. 33 LAKE | ORAL | CAPSULE | NA | NA | |||
| D&C RED NO. 33 LAKE | ORAL | TABLET | NA | 0.3mg | |||
| D&C RED NO. 36 | ORAL | TABLET | 2814779 | OE8ZA0KN9Z | 48.75mg | ||
| DIMETHICONE 350 | ORAL | CAPSULE | 9006659 | 2Y53S6ATLU | 3.7mg | ||
| DIMETHICONE 350 | ORAL | CAPSULE, EXTENDED RELEASE | 9006659 | 2Y53S6ATLU | 0.11mg | ||
| DIMETHICONE 350 | TOPICAL | CLOTH | 9006659 | 2Y53S6ATLU | NA | ||
| DIMETHICONE 350 | TOPICAL | CREAM | 9006659 | 2Y53S6ATLU | 114mg | ||
| DIMETHICONE 350 | TOPICAL | LOTION | 9006659 | 2Y53S6ATLU | 1%w/w | ||
| DIMETHICONE 350 | TOPICAL | SOLUTION | 9006659 | 2Y53S6ATLU | 0.5%w/w | ||
| DYE BLUE LAKE BLEND LB-332 | ORAL | CAPSULE | NA | 0.56mg | |||
| DYE BLUE LAKE BLEND LB-332 | ORAL | TABLET | NA | 0.11mg | |||
| DYE FDC GREEN LB-3323 | ORAL | TABLET | NA | 1.65mg | |||
| DYE GREEN LAKE BLEND LB-1236 | ORAL | TABLET | NA | 0.35mg | |||
| DYE GREEN LAKE BLEND LB-333 | ORAL | CAPSULE | NA | 6mg | |||
| DYE GREEN LAKE BLEND LB-333 | ORAL | TABLET | NA | 0.11mg | |||
| DYE GREEN LB-883 | ORAL | TABLET | NA | 0.6mg | |||
| DYE GREEN PB-1543 | ORAL | TABLET | NA | 1.2mg | |||
| DYE OCHRE 3506 | ORAL | TABLET | NA | 0.76mg | |||
| DYE OCHRE 3506 | ORAL | TABLET, COATED | NA | 0.29mg | |||
| DYE ORANGE LB-1387 | ORAL | TABLET | NA | 0.5mg | |||
| DYE ORANGE LB-1387 | ORAL | TABLET, EXTENDED RELEASE | NA | 0.4mg | |||
| DYE TAN PB-1388 | ORAL | TABLET | NA | 0.05mg | |||
| DYE TAN PB-1388 | ORAL | TABLET, FILM COATED | NA | 0.75mg | |||
| DYE YELLOW PB-1381 | ORAL | TABLET | NA | 0.2mg | |||
| ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER DISPERSION (2:1; 750000 MW 30% AQUEOUS) | ORAL | CAPSULE, EXTENDED RELEASE | 8NT5GK8OOD | 80mg | |||
| ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER DISPERSION (2:1; 750000 MW 30% AQUEOUS) | ORAL | TABLET, EXTENDED RELEASE | 8NT5GK8OOD | 235mg | |||
| ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER DISPERSION (2:1; 750000 MW 30% AQUEOUS) | ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 8NT5GK8OOD | 55mg | |||
| FD&C GREEN NO. 3 | DENTAL | GEL | 2353459 | 3P3ONR6O1S | NA | ||
| FD&C GREEN NO. 3 | ORAL | CAPSULE | 2353459 | 3P3ONR6O1S | 40mg | ||
| FD&C GREEN NO. 3 | ORAL | CAPSULE, COATED PELLETS | 2353459 | 3P3ONR6O1S | NA | ||
| FD&C GREEN NO. 3 | ORAL | CAPSULE, DELAYED RELEASE | 2353459 | 3P3ONR6O1S | 5mg | ||
| FD&C GREEN NO. 3 | ORAL | CAPSULE, EXTENDED RELEASE | 2353459 | 3P3ONR6O1S | 0.16mg | ||
| FD&C GREEN NO. 3 | ORAL | CAPSULE, LIQUID FILLED | 2353459 | 3P3ONR6O1S | 0.02mg | ||
| FD&C GREEN NO. 3 | ORAL | ELIXIR | 2353459 | 3P3ONR6O1S | NA | ||
| FD&C GREEN NO. 3 | ORAL | SOLUTION | 2353459 | 3P3ONR6O1S | 0.25mg/5ml | ||
| FD&C GREEN NO. 3 | ORAL | SYRUP | 2353459 | 3P3ONR6O1S | 3.75mg/5ml | ||
| FD&C GREEN NO. 3 | ORAL | TABLET | 2353459 | 3P3ONR6O1S | 240mg | ||
| FD&C GREEN NO. 3 | ORAL | TABLET, COATED | 2353459 | 3P3ONR6O1S | 0.01mg | ||
| FD&C GREEN NO. 3 | ORAL | TABLET, DELAYED RELEASE | 2353459 | 3P3ONR6O1S | NA | ||
| FD&C GREEN NO. 3 | RECTAL | SUPPOSITORY | 2353459 | 3P3ONR6O1S | 0.02mg | ||
| FD&C GREEN NO. 3 | TOPICAL | SHAMPOO | 2353459 | 3P3ONR6O1S | 0.09%w/w | ||
| FD&C GREEN NO. 3 | TOPICAL | SOLUTION | 2353459 | 3P3ONR6O1S | NA | ||
| FD&C GREEN NO. 3, ALUMINUM LAKE | ORAL | CAPSULE | 117804996 | NA | 0.01mg | ||
| FD&C RED NO. 3 | ORAL | CAPSULE | 49746103 | PN2ZH5LOQY | 11.69mg | ||
| FD&C RED NO. 3 | ORAL | CAPSULE, DELAYED RELEASE | 49746103 | PN2ZH5LOQY | 0.09mg | ||
| FD&C RED NO. 3 | ORAL | CAPSULE, EXTENDED RELEASE | 49746103 | PN2ZH5LOQY | 0.39mg | ||
| FD&C RED NO. 3 | ORAL | DROPS | 49746103 | PN2ZH5LOQY | NA | ||
| FD&C RED NO. 3 | ORAL | ELIXIR | 49746103 | PN2ZH5LOQY | 0.04mg/5ml | ||
| FD&C RED NO. 3 | ORAL | POWDER, FOR SOLUTION | 49746103 | PN2ZH5LOQY | NA | ||
| FD&C RED NO. 3 | ORAL | POWDER, FOR SUSPENSION | 49746103 | PN2ZH5LOQY | 0.75mg | ||
| FD&C RED NO. 3 | ORAL | SUSPENSION | 49746103 | PN2ZH5LOQY | 1mg/5ml | ||
| FD&C RED NO. 3 | ORAL | SUSPENSION/ DROPS | 49746103 | PN2ZH5LOQY | 0.13mg/2.5ml | ||
| FD&C RED NO. 3 | ORAL | SYRUP | 49746103 | PN2ZH5LOQY | 0.15mg/5ml | ||
| FD&C RED NO. 3 | ORAL | TABLET | 49746103 | PN2ZH5LOQY | 2.2mg | ||
| FD&C RED NO. 3 | ORAL | TABLET, CHEWABLE | 49746103 | PN2ZH5LOQY | 1mg | ||
| FD&C RED NO. 3 | ORAL | TABLET, COATED | 49746103 | PN2ZH5LOQY | 0.5mg | ||
| FD&C RED NO. 3 | ORAL | TABLET, DELAYED RELEASE | 49746103 | PN2ZH5LOQY | NA | ||
| FD&C RED NO. 3 | ORAL | TABLET, EXTENDED RELEASE | 49746103 | PN2ZH5LOQY | 0.07mg | ||
| FD&C RED NO. 3 | ORAL | TABLET, FILM COATED | 49746103 | PN2ZH5LOQY | 0.02mg | ||
| FD&C RED NO. 3 | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 49746103 | PN2ZH5LOQY | NA | ||
| FD&C RED NO. 30--ALUMINUM LAKE | ORAL | CAPSULE, EXTENDED RELEASE | NA | NA | |||
| FD&C RED NO. 30--ALUMINUM LAKE | ORAL | TABLET | NA | 2mg | |||
| FD&C RED NO. 30--ALUMINUM LAKE | ORAL | TABLET, COATED | NA | NA | |||
| FD&C RED NO. 30--ALUMINUM LAKE | ORAL | TABLET, EXTENDED RELEASE | NA | 0.32mg | |||
| FILM COATING SOLUTION, AQUEOUS IM-163 | ORAL | TABLET | NA | 20mg | |||
| FILM COATING SOLUTION, AQUEOUS IM-163 | ORAL | TABLET, FILM COATED | NA | 6.3mg | |||
| FLAVOR BANANA 15223 | ORAL | POWDER, FOR SUSPENSION | NA | 250mg | |||
| FLAVOR BANANA 501013 AP0551 | ORAL | POWDER, FOR SUSPENSION | NA | 168mg | |||
| FLAVOR BANANA 8763 | ORAL | SOLUTION | NA | NA | |||
| FLAVOR BANANA FN-6713 | ORAL | SOLUTION | NA | 160mg | |||
| FLAVOR BITTERNESS MODIFIER 36734 | ORAL | SYRUP | NA | 1mg/1ml | |||
| FLAVOR BUBBLE GUM MC-4938 | ORAL | SUSPENSION | NA | 18mg/5ml | |||
| FLAVOR BUBBLE GUM MC-4938 | ORAL | SYRUP | NA | 5mg | |||
| FLAVOR CHERI-BERI PFC-8573 | ORAL | POWDER, FOR SUSPENSION | NA | 25mg/5ml | |||
| FLAVOR CHERRY 349 | ORAL | SOLUTION | NA | 16.45mg/5ml | |||
| FLAVOR CHERRY 349 | ORAL | SUSPENSION | NA | 40mg | |||
| FLAVOR CHERRY 8513 | ORAL | SOLUTION | NA | 36mg | |||
| FLAVOR CHERRY 8513 | ORAL | SYRUP | NA | NA | |||
| FLAVOR CHERRY F-232 | ORAL | CONCENTRATE | NA | NA | |||
| FLAVOR CHERRY F-232 | ORAL | SOLUTION | NA | 15mg/5ml | |||
| FLAVOR CHERRY F-232 | ORAL | SUSPENSION | NA | NA | |||
| FLAVOR CHERRY FMC 8513 | ORAL | SOLUTION | NA | NA | |||
| FLAVOR CHERRY FMC 8513 | ORAL | SYRUP | NA | NA | |||
| FLAVOR CHERRY WL-1093 | ORAL | SOLUTION | NA | 1.6mg/5ml | |||
| FLAVOR CHERRY WL-1093 | ORAL | SYRUP | NA | 4mg/5ml | |||
| FLAVOR CINNAMON VEKO 3726 | BUCCAL | GUM, CHEWING | NA | 648mg | |||
| FLAVOR CREAMY VANILLA 16345 | ORAL | SOLUTION | NA | NA | |||
| FLAVOR F-5397A | ORAL | CONCENTRATE | NA | 0.08ml/1ml | |||
| FLAVOR GRAPE 10273 | ORAL | SOLUTION | NA | 165mg | |||
| FLAVOR GRAPE 61.13252 | ORAL | SOLUTION | NA | 20mg | |||
| FLAVOR GRAPE MANHEIMER 522463 | ORAL | SOLUTION | NA | 4.38mg/1ml | |||
| FLAVOR GRAPE MANHEIMER 522463 | ORAL | SUSPENSION | NA | 25mg/5ml | |||
| FLAVOR GRAPE ST6835/09 | ORAL | SOLUTION | NA | 3.11mg/5ml | |||
| FLAVOR GRAPE ST6835/09 | ORAL | SYRUP | NA | 3.11mg/5ml | |||
| FLAVOR LEMON LIME SD 935 | ORAL | TABLET, ORALLY DISINTEGRATING | NA | 38mg | |||
| FLAVOR LEMON LIME SD 935 | SUBLINGUAL | FILM | NA | 9mg | |||
| FLAVOR LEMON LIME SD 935 | SUBLINGUAL | TABLET | NA | 2mg | |||
| FLAVOR LEMON N&A 397 | ORAL | POWDER, FOR SUSPENSION | NA | 35mg | |||
| FLAVOR LEMON N&A 397 | SUBLINGUAL | TABLET | NA | 6mg | |||
| FLAVOR LEMON SPRAY V3938-1N1 | ORAL | POWDER, FOR SOLUTION | NA | 340mg | |||
| FLAVOR LEMON SPRAY V3938-1N1 | ORAL | POWDER, FOR SUSPENSION | NA | 167mg | |||
| FLAVOR MINT SN027513 | ORAL | TABLET | NA | 1.5mg | |||
| FLAVOR MINT SN027513 | ORAL | TABLET, ORALLY DISINTEGRATING | NA | 9.31mg | |||
| FLAVOR MIXED BERRY 13.13489 | ORAL | SUSPENSION | NA | 43mg | |||
| FLAVOR ORANGE 739K (PB82) | ORAL | POWDER, FOR SUSPENSION | NA | 40mg | |||
| FLAVOR ORANGE 9/79J839 | ORAL | POWDER, FOR SUSPENSION | NA | 60mg | |||
| FLAVOR ORANGE 9/79J839 | ORAL | SUSPENSION | NA | 36mg | |||
| FLAVOR ORANGE GIVAUDAN 74388-74 | ORAL | SUSPENSION | NA | 6mg | |||
| FLAVOR PEACH 13503584 | ORAL | SOLUTION | NA | NA | |||
| FLAVOR PEACH 13503584 | ORAL | SYRUP | NA | 3.7mg/5ml | |||
| FLAVOR PEPPERMINT EXTRACT FN-2356 | ORAL | SOLUTION | NA | 288mg | |||
| FLAVOR PEPPERMINT FM-4134 | ORAL | SOLUTION | NA | 25mg | |||
| FLAVOR PEPPERMINT SN583865 | ORAL | SOLUTION | NA | NA | |||
| FLAVOR PEPPERMINT WONF 33864 | ORAL | LOZENGE | NA | 600mg | |||
| FLAVOR ROOT BEER 180339 | ORAL | POWDER, FOR SUSPENSION | NA | 2.1mg/5ml | |||
| FLAVOR STRAWBERRY 052311 AP0551 | ORAL | POWDER, FOR SUSPENSION | NA | 35mg/5ml | |||
| FLAVOR STRAWBERRY 052311 AP0551 | ORAL | TABLET, ORALLY DISINTEGRATING | NA | 3mg | |||
| FLAVOR STRAWBERRY 052311 AP0551 | ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | NA | 35mg | |||
| FLAVOR STRAWBERRY 14953 | ORAL | SOLUTION | NA | NA | |||
| FLAVOR STRAWBERRY 17.36.8509 | ORAL | TABLET | NA | 78mg | |||
| FLAVOR STRAWBERRY 17.36.8509 | ORAL | TABLET, ORALLY DISINTEGRATING | NA | 12mg | |||
| FLAVOR STRAWBERRY 17.36.8509 | ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | NA | 66mg | |||
| FLAVOR STRAWBERRY 52.311AP | ORAL | POWDER, FOR SUSPENSION | NA | 25mg/5ml | |||
| FLAVOR STRAWBERRY 52312/AP0551 | ORAL | POWDER, FOR SUSPENSION | NA | 15mg/5ml | |||
| FLAVOR STRAWBERRY FN-13819 | ORAL | SOLUTION | NA | 261mg | |||
| FLAVOR SWEET TONE 28837 | ORAL | SOLUTION | NA | 0.5mg/5ml | |||
| FLAVOR TROPICAL FRUIT PUNCH N&A 50432 | ORAL | SOLUTION | NA | 8mg | |||
| FLAVOR TROPICAL FRUIT PUNCH N&A 50432 | ORAL | SYRUP | NA | 5.2mg/1ml | |||
| FLAVOR TUTTI FRUTTI PERMASEAL 77919-31 | ORAL | SOLUTION | NA | 1mg | |||
| FLAVOR TUTTI FRUTTI PERMASEAL 77919-31 | ORAL | TABLET, ORALLY DISINTEGRATING | NA | 0.2mg | |||
| FLAVOR VANILLA 20.4573.5P PHA | ORAL | POWDER, FOR SUSPENSION | NA | 4mg | |||
| FLAVOR VANILLA 20.4573.5P PHA | ORAL | TABLET, ORALLY DISINTEGRATING | NA | 8mg | |||
| FLAVOR WILD CHERRY GIVAUDAN F-1813 | ORAL | POWDER, FOR SOLUTION | NA | 2000mg/5ml | |||
| FLAVOR WILD CHERRY GIVAUDAN F-1813 | ORAL | POWDER, FOR SUSPENSION | NA | 68.2mg/5ml | |||
| FLAVOR WILD CHERRY NO. 24038 | ORAL | CONCENTRATE | NA | 120mg | |||
| FLAVOR WILD CHERRY NO. 24038 | ORAL | SOLUTION | NA | 26mg | |||
| FLAVOR WILD CHERRY NO. 24038 | ORAL | SUSPENSION | NA | 16mg | |||
| FLAVOR WILD CHERRY PFC-14783 | ORAL | SUSPENSION | NA | 0.37mg/1ml | |||
| FLAVOR WILD CHERRY PFC-14783 | ORAL | SYRUP | NA | 12.5mg/5ml | |||
| FLAVOR YELLOW PLUM LEMON 39K 020 | ORAL | SUSPENSION | NA | 100mg | |||
| FRAGRANCE CREAM NO. 73457 | TOPICAL | OIL | NA | 1.15%w/w | |||
| GLYCERIN POLYMER SOLUTION I-137 | ORAL | TABLET | NA | 0.5mg | |||
| GLYCERIN POLYMER SOLUTION IM-137 | ORAL | TABLET | NA | NA | |||
| HYDROXYPROPYL CELLULOSE (430000 WAMW) | ORAL | TABLET | 9004642 | VQ8ZWO78F6 | 18mg | ||
| HYDROXYPROPYL CELLULOSE (430000 WAMW) | ORAL | TABLET, EXTENDED RELEASE | 9004642 | VQ8ZWO78F6 | 170mg | ||
| HYDROXYPROPYL CELLULOSE (430000 WAMW) | TOPICAL | LOTION, AUGMENTED | 9004642 | VQ8ZWO78F6 | 37mg | ||
| HYDROXYPROPYL CELLULOSE (430000 WAMW) | TOPICAL | SOLUTION | 9004642 | VQ8ZWO78F6 | 200mg | ||
| HYPROMELLOSE 2208 (3 MPA.S) | ORAL | CAPSULE | 9004653 | 9H4L916OBU | 19mg | ||
| HYPROMELLOSE 2208 (3 MPA.S) | ORAL | CAPSULE, DELAYED RELEASE | 9004653 | 9H4L916OBU | 40mg | ||
| HYPROMELLOSE 2208 (3 MPA.S) | ORAL | CAPSULE, EXTENDED RELEASE | 9004653 | 9H4L916OBU | 24mg | ||
| HYPROMELLOSE 2208 (3 MPA.S) | ORAL | SUSPENSION | 9004653 | 9H4L916OBU | 15mg | ||
| HYPROMELLOSE 2208 (3 MPA.S) | ORAL | TABLET | 9004653 | 9H4L916OBU | 428mg | ||
| HYPROMELLOSE 2208 (3 MPA.S) | ORAL | TABLET, DELAYED RELEASE | 9004653 | 9H4L916OBU | 7mg | ||
| HYPROMELLOSE 2208 (3 MPA.S) | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 9004653 | 9H4L916OBU | 470mg | ||
| HYPROMELLOSE 2910 (3 MPA.S) | OPHTHALMIC | SOLUTION/ DROPS | 9004653 | 0VUT3PMY82 | 0.5%w/v | ||
| HYPROMELLOSE 2910 (3 MPA.S) | ORAL | CAPSULE | 9004653 | 0VUT3PMY82 | 400mg | ||
| HYPROMELLOSE 2910 (3 MPA.S) | ORAL | CAPSULE, DELAYED RELEASE | 9004653 | 0VUT3PMY82 | 721mg | ||
| HYPROMELLOSE 2910 (3 MPA.S) | ORAL | CAPSULE, EXTENDED RELEASE | 9004653 | 0VUT3PMY82 | 105mg | ||
| HYPROMELLOSE 2910 (3 MPA.S) | ORAL | GRANULE | 9004653 | 0VUT3PMY82 | 295mg | ||
| HYPROMELLOSE 2910 (3 MPA.S) | ORAL | GRANULE, FOR SUSPENSION | 9004653 | 0VUT3PMY82 | 1mg | ||
| HYPROMELLOSE 2910 (3 MPA.S) | ORAL | SUSPENSION | 9004653 | 0VUT3PMY82 | 156mg | ||
| HYPROMELLOSE 2910 (3 MPA.S) | ORAL | TABLET | 9004653 | 0VUT3PMY82 | 379mg | ||
| HYPROMELLOSE 2910 (3 MPA.S) | ORAL | TABLET, COATED | 9004653 | 0VUT3PMY82 | 7.5mg | ||
| HYPROMELLOSE 2910 (3 MPA.S) | ORAL | TABLET, DELAYED RELEASE | 9004653 | 0VUT3PMY82 | 140mg | ||
| HYPROMELLOSE 2910 (3 MPA.S) | ORAL | TABLET, EXTENDED RELEASE | 9004653 | 0VUT3PMY82 | 231mg | ||
| HYPROMELLOSE 2910 (3 MPA.S) | ORAL | TABLET, FILM COATED | 9004653 | 0VUT3PMY82 | 78mg | ||
| HYPROMELLOSE 2910 (3 MPA.S) | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 9004653 | 0VUT3PMY82 | 8mg | ||
| HYPROMELLOSE 2910 (3 MPA.S) | ORAL | TABLET, FOR SUSPENSION | 9004653 | 0VUT3PMY82 | 60mg | ||
| HYPROMELLOSE 2910 (3 MPA.S) | ORAL | TABLET, ORALLY DISINTEGRATING | 9004653 | 0VUT3PMY82 | 52mg | ||
| HYPROMELLOSE 2910 (3 MPA.S) | ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 9004653 | 0VUT3PMY82 | 36mg | ||
| HYPROMELLOSE ACETATE SUCCINATE 06081224 (3 MPA.S) | ORAL | CAPSULE, EXTENDED RELEASE | 71138971 | 6N003M473W | 57mg | ||
| HYPROMELLOSE ACETATE SUCCINATE 06081224 (3 MPA.S) | ORAL | GRANULE | 71138971 | 6N003M473W | 92mg | ||
| HYPROMELLOSE ACETATE SUCCINATE 12070923 (3 MPA.S) | ORAL | CAPSULE, DELAYED RELEASE | 71138971 | 36BGF0E889 | 104mg | ||
| HYPROMELLOSE ACETATE SUCCINATE 12070923 (3 MPA.S) | ORAL | TABLET, DELAYED RELEASE | 71138971 | 36BGF0E889 | 2720mg | ||
| HYPROMELLOSE ACETATE SUCCINATE 16070722 (3 MPA.S) | ORAL | CAPSULE, DELAYED RELEASE | 71138971 | 24P2YXD2PW | 99mg | ||
| HYPROMELLOSE ACETATE SUCCINATE 16070722 (3 MPA.S) | ORAL | TABLET, EXTENDED RELEASE | 71138971 | 24P2YXD2PW | 26mg | ||
| HYPROMELLOSE PHTHALATE (31% PHTHALATE, 170 CST) | ORAL | CAPSULE, DELAYED RELEASE | 9050311 | 8LDD2V82F5 | 129mg | ||
| HYPROMELLOSE PHTHALATE (31% PHTHALATE, 170 CST) | ORAL | TABLET, DELAYED RELEASE | 9050311 | 8LDD2V82F5 | 49mg | ||
| HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST) | ORAL | CAPSULE | 9050311 | G4U024CQK6 | 63.92mg | ||
| HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST) | ORAL | CAPSULE, DELAYED RELEASE | 9050311 | G4U024CQK6 | 586mg | ||
| HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST) | ORAL | CAPSULE, EXTENDED RELEASE | 9050311 | G4U024CQK6 | 44mg | ||
| HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST) | ORAL | GRANULE, FOR SUSPENSION | 9050311 | G4U024CQK6 | 1217mg | Y | |
| HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST) | ORAL | TABLET | 9050311 | G4U024CQK6 | 152mg | ||
| HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST) | ORAL | TABLET, EXTENDED RELEASE | 9050311 | G4U024CQK6 | 13mg | ||
| INK BLACK FGE-1386 | ORAL | CAPSULE | NA | NA | |||
| INK RED A-8032 | ORAL | CAPSULE | NA | NA | |||
| INK RED A-8032 | ORAL | TABLET, COATED | NA | NA | |||
| KOLLICOAT SR 30D | ORAL | TABLET, EXTENDED RELEASE | IDP0HWP8PJ | 480mg | |||
| KOLLICOAT SR 30D | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | IDP0HWP8PJ | 22.28mg | |||
| LAURETH-23 | TOPICAL | AEROSOL | 9002920 | N72LMW566G | 0.45%w/w | ||
| LAURETH-23 | TOPICAL | AEROSOL, FOAM | 9002920 | N72LMW566G | 1.08%w/w | ||
| LAURETH-23 | TOPICAL | CREAM | 9002920 | N72LMW566G | NA | ||
| LAURETH-23 | TOPICAL | EMULSION | 9002920 | N72LMW566G | 0.45%w/w | ||
| LAURETH-23 | TOPICAL | LOTION | 9002920 | N72LMW566G | NA | ||
| LAUROYL PEG-32 GLYCERIDES | ORAL | CAPSULE | 121548047 | H5ZC52369M | 7200mg | ||
| LAUROYL PEG-32 GLYCERIDES | ORAL | TABLET | 121548047 | H5ZC52369M | 0.15mg | ||
| LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 130000 MW) | ORAL | CAPSULE | 9004642 | 7773C1ROEU | 200mg | ||
| LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 130000 MW) | ORAL | CAPSULE, EXTENDED RELEASE | 9004642 | 7773C1ROEU | 16.25mg | ||
| LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 130000 MW) | ORAL | TABLET | 9004642 | 7773C1ROEU | 512mg | ||
| LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 130000 MW) | ORAL | TABLET, CHEWABLE | 9004642 | 7773C1ROEU | 48mg | ||
| LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 130000 MW) | ORAL | TABLET, DELAYED RELEASE | 9004642 | 7773C1ROEU | 180mg | ||
| LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 130000 MW) | ORAL | TABLET, DELAYED RELEASE PARTICLES | 9004642 | 7773C1ROEU | 30mg | ||
| LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 130000 MW) | ORAL | TABLET, FILM COATED | 9004642 | 7773C1ROEU | 50mg | ||
| LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 130000 MW) | ORAL | TABLET, FOR SUSPENSION | 9004642 | 7773C1ROEU | 320mg | ||
| LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 130000 MW) | ORAL | TABLET, ORALLY DISINTEGRATING | 9004642 | 7773C1ROEU | 60mg | ||
| OPACOAT NA7013 CLEAR | ORAL | TABLET, EXTENDED RELEASE | NA | 4mg | |||
| OPACODE NSP-78-17734 BLACK | ORAL | CAPSULE | NA | NA | |||
| OPACODE S-1-13001 ORANGE | ORAL | TABLET | NA | 0.03mg | |||
| OPACODE S-1-17734 BLACK | ORAL | TABLET, FILM COATED | NA | NA | |||
| OPACODE S-1-17823 BLACK | ORAL | CAPSULE | 3Z4GL78VFW | 1mg | |||
| OPACODE S-1-17823 BLACK | ORAL | TABLET | 3Z4GL78VFW | 1mg | |||
| OPACODE S-1-17823 BLACK | ORAL | TABLET, EXTENDED RELEASE | 3Z4GL78VFW | 1mg | |||
| OPACODE S-1-3110 GREEN | ORAL | TABLET | NA | NA | |||
| OPACODE S-1-9032 | ORAL | TABLET | NA | 9mg | |||
| OPADRY 00B57513 GREY | ORAL | TABLET | NA | 15mg | |||
| OPADRY 00B57513 GREY | ORAL | TABLET, EXTENDED RELEASE | NA | 5mg | |||
| OPADRY 03B11434 GREEN | ORAL | TABLET | NA | 65mg | |||
| OPADRY 03B12878 YELLOW | ORAL | TABLET, EXTENDED RELEASE | NA | 26mg | |||
| OPADRY 03B14436 PINK | ORAL | TABLET | 4LK0LJX5WB | 24mg | |||
| OPADRY 03B14436 PINK | ORAL | TABLET, EXTENDED RELEASE | 4LK0LJX5WB | 14mg | |||
| OPADRY 03B17495 BEIGE | ORAL | TABLET | NA | 18mg | |||
| OPADRY 03B17495 BEIGE | ORAL | TABLET, FILM COATED | NA | 2.4mg | |||
| OPADRY 03B20024 PURPLE | ORAL | TABLET, EXTENDED RELEASE | NA | 13mg | |||
| OPADRY 03B20024 PURPLE | ORAL | TABLET, FILM COATED | NA | 3mg | |||
| OPADRY 03B20556 BLUE | ORAL | TABLET, EXTENDED RELEASE | NA | 10mg | |||
| OPADRY 03B22082 YELLOW | ORAL | TABLET | NA | 48mg | |||
| OPADRY 03B240011 PINK | ORAL | TABLET | NA | 54mg | |||
| OPADRY 03B28796 WHITE | ORAL | TABLET | R2M5KK65A9 | 63mg | |||
| OPADRY 03B28796 WHITE | ORAL | TABLET, COATED | R2M5KK65A9 | 54mg | |||
| OPADRY 03B28796 WHITE | ORAL | TABLET, EXTENDED RELEASE | R2M5KK65A9 | 64mg | |||
| OPADRY 03B28796 WHITE | ORAL | TABLET, FILM COATED | R2M5KK65A9 | 27mg | |||
| OPADRY 03B32034 YELLOW | ORAL | TABLET, EXTENDED RELEASE | NA | 92mg | |||
| OPADRY 03B34399 PINK | ORAL | TABLET | NA | 19.05mg | |||
| OPADRY 03B52155 YELLOW | ORAL | TABLET | NA | 27mg | |||
| OPADRY 03B56518 BROWN | ORAL | TABLET | NA | 3mg | |||
| OPADRY 03B56518 BROWN | ORAL | TABLET, FILM COATED | NA | 4mg | |||
| OPADRY 03B57519 GREY | ORAL | TABLET | M67GSV4XEH | 13mg | |||
| OPADRY 03B57519 GREY | ORAL | TABLET, EXTENDED RELEASE | M67GSV4XEH | 12.07mg | |||
| OPADRY 03B58902 WHITE | ORAL | TABLET | NA | 21mg | |||
| OPADRY 03B68903 WHITE | ORAL | TABLET | NA | 57mg | |||
| OPADRY 03B80829 BLUE | ORAL | TABLET | NA | 3mg | |||
| OPADRY 03B80829 BLUE | ORAL | TABLET, EXTENDED RELEASE | NA | 4.5mg | |||
| OPADRY 03B82316 YELLOW | ORAL | TABLET | NA | 35mg | |||
| OPADRY 03B86636 BROWN | ORAL | TABLET, DELAYED RELEASE | NA | 9mg | |||
| OPADRY 03F12967 YELLOW | ORAL | TABLET | NA | 6mg | |||
| OPADRY 03F12967 YELLOW | ORAL | TABLET, FILM COATED | NA | 4mg | |||
| OPADRY 03F14895 PINK | ORAL | TABLET | NA | 6mg | |||
| OPADRY 03F14895 PINK | ORAL | TABLET, FILM COATED | NA | 8mg | |||
| OPADRY 03F43101 ORANGE | ORAL | TABLET | NA | 7mg | |||
| OPADRY 03F505071 BLUE | ORAL | TABLET | NA | 5mg | |||
| OPADRY 03F58991 WHITE | ORAL | TABLET | NA | 36mg | |||
| OPADRY 03F59016 CLEAR | ORAL | CAPSULE, EXTENDED RELEASE | NA | 56mg | |||
| OPADRY 03F59016 CLEAR | ORAL | TABLET | NA | 114mg | |||
| OPADRY 03F59016 CLEAR | ORAL | TABLET, EXTENDED RELEASE | NA | 8mg | |||
| OPADRY 03F82726 YELLOW | ORAL | TABLET | H82AGY7EQQ | 7mg | |||
| OPADRY 03F82726 YELLOW | ORAL | TABLET, FILM COATED | H82AGY7EQQ | 7mg | |||
| OPADRY 03F82788 YELLOW | ORAL | TABLET | NA | 60mg | |||
| OPADRY 03G24389 PINK | ORAL | TABLET, DELAYED RELEASE | NA | 40mg | |||
| OPADRY 03G24389 PINK | ORAL | TABLET, FILM COATED | NA | 9mg | |||
| OPADRY 03K19229 CLEAR | ORAL | TABLET | NA | 4.3mg | |||
| OPADRY 03K19229 CLEAR | ORAL | TABLET, DELAYED RELEASE | NA | 8.4mg | |||
| OPADRY 03K19229 CLEAR | ORAL | TABLET, EXTENDED RELEASE | NA | 64mg | |||
| OPADRY 03K29121 CLEAR | ORAL | TABLET, DELAYED RELEASE | NA | 46mg | |||
| OPADRY 03K54121 PINK | ORAL | TABLET | NA | 10mg | |||
| OPADRY 03K80846 BLUE | ORAL | TABLET | NA | 15mg | |||
| OPADRY 05B15325 RED | ORAL | TABLET | NA | 5mg | |||
| OPADRY 13B58802 WHITE | ORAL | TABLET | NA | 30mg | |||
| OPADRY 13B58802 WHITE | ORAL | TABLET, COATED | NA | 40mg | |||
| OPADRY 13B58802 WHITE | ORAL | TABLET, FILM COATED | NA | 30mg | |||
| OPADRY 13B58894 WHITE | ORAL | TABLET | NA | 60mg | |||
| OPADRY 13B58894 WHITE | ORAL | TABLET, EXTENDED RELEASE | NA | 61mg | |||
| OPADRY 13F58866 WHITE | ORAL | TABLET | NA | 3mg | |||
| OPADRY 13F58866 WHITE | ORAL | TABLET, FILM COATED | NA | 4.5mg | |||
| OPADRY 13K52177 YELLOW | ORAL | TABLET | NA | 40mg | |||
| OPADRY 13M86920 BROWN | ORAL | TABLET | NA | 28mg | |||
| OPADRY 20B50135 PURPLE | ORAL | TABLET, FILM COATED | NA | 25mg | |||
| OPADRY 321A180025 WHITE | ORAL | TABLET, FILM COATED | NA | 40mg | |||
| OPADRY 32K14834 PINK | ORAL | TABLET, FILM COATED | NA | 56mg | |||
| OPADRY 85G689183 WHITE | ORAL | TABLET | NA | 27mg | |||
| OPADRY 85G93096 ORANGE | ORAL | TABLET | NA | 4.53mg | |||
| OPADRY AMB 80W64837 PINK | ORAL | TABLET | NA | 40mg | |||
| OPADRY II 31F23111 ORANGE | ORAL | TABLET, DELAYED RELEASE | NA | 8mg | |||
| OPADRY II 31F23111 ORANGE | ORAL | TABLET, EXTENDED RELEASE | NA | 16mg | |||
| OPADRY II 31F58914 WHITE | ORAL | TABLET | NA | 92mg | |||
| OPADRY II 31K58902 WHITE | ORAL | TABLET | NA | 108mg | |||
| OPADRY II 31K84972 PINK | ORAL | TABLET | NA | 29.1mg | |||
| OPADRY II 31K84972 PINK | ORAL | TABLET, FILM COATED | NA | 10mg | |||
| OPADRY II 32B10817 BLUE | ORAL | TABLET | NA | 6mg | |||
| OPADRY II 32K12884 YELLOW | ORAL | TABLET | NA | 14mg | |||
| OPADRY II 32K13357 ORANGE | ORAL | TABLET | NA | 5mg | |||
| OPADRY II 32K14833 PINK | ORAL | TABLET | NA | 21mg | |||
| OPADRY II 32K14833 PINK | ORAL | TABLET, FILM COATED | NA | 5mg | |||
| OPADRY II 32K17573 GRAY | ORAL | TABLET | NA | 7.5mg | |||
| OPADRY II 32K17573 GRAY | ORAL | TABLET, EXTENDED RELEASE | NA | 14mg | |||
| OPADRY II 33G11938 GREEN | ORAL | TABLET | B53ZH89YAO | 16mg | |||
| OPADRY II 33G28435 WHITE | ORAL | TABLET | NA | 22.5mg | Y | ||
| OPADRY II 33G28523 WHITE | ORAL | TABLET | NA | 18mg | |||
| OPADRY II 33G28707 WHITE | ORAL | TABLET | NA | 31.25mg | |||
| OPADRY II 33G28707 WHITE | ORAL | TABLET, DELAYED RELEASE | NA | 42mg | |||
| OPADRY II 33G28707 WHITE | ORAL | TABLET, EXTENDED RELEASE | NA | 60mg | |||
| OPADRY II 33G28707 WHITE | ORAL | TABLET, FILM COATED | NA | 6mg | |||
| OPADRY II 39B18529 WHITE | ORAL | TABLET, EXTENDED RELEASE | NA | 23mg | |||
| OPADRY II 40C18303 WHITE | ORAL | TABLET | NA | NA | |||
| OPADRY II 40C18303 WHITE | ORAL | TABLET, FILM COATED | NA | 6mg | |||
| OPADRY II 40L10039 PURPLE | ORAL | TABLET | NA | 28mg | |||
| OPADRY II 40L10039 PURPLE | ORAL | TABLET, FILM COATED | NA | 4mg | |||
| OPADRY II 40L11438 GREEN | ORAL | TABLET, EXTENDED RELEASE | NA | 48mg | |||
| OPADRY II 40L13950 ORANGE | ORAL | TABLET | NA | 9mg | |||
| OPADRY II 85F130017 ORANGE | ORAL | TABLET | NA | 5.3mg | |||
| OPADRY II 85F13980 ORANGE | ORAL | TABLET | NA | 54mg | Y | ||
| OPADRY II 85F14399 PINK | ORAL | TABLET | NA | 16mg | |||
| OPADRY II 85F18378 WHITE | ORAL | CAPSULE | VTB5DCJ7N6 | 405mg | |||
| OPADRY II 85F18378 WHITE | ORAL | CAPSULE, EXTENDED RELEASE | VTB5DCJ7N6 | 4mg | |||
| OPADRY II 85F18378 WHITE | ORAL | TABLET | VTB5DCJ7N6 | 80mg | |||
| OPADRY II 85F18378 WHITE | ORAL | TABLET, DELAYED RELEASE | VTB5DCJ7N6 | 100mg | |||
| OPADRY II 85F18378 WHITE | ORAL | TABLET, EXTENDED RELEASE | VTB5DCJ7N6 | 140mg | |||
| OPADRY II 85F23470 PINK | ORAL | TABLET | NA | 7.5mg | |||
| OPADRY II 85F24307 PINK | ORAL | TABLET | NA | 70mg | |||
| OPADRY II 85F24307 PINK | ORAL | TABLET, FILM COATED | NA | 4mg | |||
| OPADRY II 85F32121 YELLOW | ORAL | TABLET | NA | 2mg | |||
| OPADRY II 85F32782 YELLOW | ORAL | TABLET | NA | 15mg | |||
| OPADRY II 85F32782 YELLOW | ORAL | TABLET, FILM COATED | NA | 10.5mg | |||
| OPADRY II 85F34610 PINK | ORAL | TABLET | NA | 8mg | |||
| OPADRY II 85F64732 PINK | ORAL | TABLET | NA | 4.65mg | |||
| OPADRY II 85F90093 PURPLE | ORAL | TABLET | NA | 114mg | |||
| OPADRY II 85F90093 PURPLE | ORAL | TABLET, COATED | NA | 67mg | |||
| OPADRY II 85G20583 BLUE | ORAL | TABLET | NA | 192mg | |||
| OPADRY II Y-19-7483 CLEAR | ORAL | CAPSULE, EXTENDED RELEASE | NA | 19mg | |||
| OPADRY II Y-19-7483 CLEAR | ORAL | TABLET | NA | 5.6mg | |||
| OPADRY II Y-19-7483 CLEAR | ORAL | TABLET, DELAYED RELEASE | NA | 48mg | |||
| OPADRY II Y-19-7483 CLEAR | ORAL | TABLET, EXTENDED RELEASE | NA | 85mg | |||
| OPADRY II Y-19-7483 CLEAR | ORAL | TABLET, FILM COATED | NA | 34mg | |||
| OPADRY II Y-22-10538 BLUE | ORAL | TABLET | NA | 90mg | |||
| OPADRY II Y-22-12553 YELLOW | ORAL | TABLET | NA | 242mg | |||
| OPADRY II Y-22-13061 ORANGE | ORAL | TABLET | NA | 72mg | |||
| OPADRY II Y-22-13061 ORANGE | ORAL | TABLET, COATED | NA | 13mg | |||
| OPADRY II Y-22-13061 ORANGE | ORAL | TABLET, EXTENDED RELEASE | NA | 40mg | |||
| OPADRY II Y-22-13061 ORANGE | ORAL | TABLET, FILM COATED | NA | 6.5mg | |||
| OPADRY II Y-22-13083 ORANGE | ORAL | TABLET | NA | 15mg | |||
| OPADRY II Y-22-13167 ORANGE | ORAL | TABLET | NA | 25mg | |||
| OPADRY II Y-22-13167 ORANGE | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | NA | 34mg | |||
| OPADRY II Y-22-13577 FLESH | ORAL | TABLET | NA | 126mg | |||
| OPADRY II Y-22-13577 FLESH | ORAL | TABLET, EXTENDED RELEASE | NA | 15mg | |||
| OPADRY II Y-22-13577 FLESH | ORAL | TABLET, FILM COATED | NA | 9.3mg | |||
| OPADRY II Y-22-13603 ORANGE | ORAL | TABLET | NA | 67.5mg | |||
| OPADRY II Y-22-13603 ORANGE | ORAL | TABLET, EXTENDED RELEASE | NA | 142mg | |||
| OPADRY II Y-30-10671A BLUE | ORAL | TABLET | NA | 20mg | |||
| OPADRY II Y-30-12736A YELLOW | ORAL | TABLET | NA | 21mg | |||
| OPADRY II Y-30-12736A YELLOW | ORAL | TABLET, FILM COATED | NA | 18mg | |||
| OPADRY II Y-30-12736A YELLOW | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | NA | 7mg | |||
| OPADRY II Y-30-12737A YELLOW | ORAL | TABLET | NA | 6mg | |||
| OPADRY II Y-30-12737A YELLOW | ORAL | TABLET, COATED | NA | 6mg | |||
| OPADRY II Y-30-12737A YELLOW | ORAL | TABLET, FILM COATED | NA | 5mg | |||
| OPADRY II Y-30-17528 GRAY | ORAL | TABLET | NA | 25mg | |||
| OPADRY II Y-30-17528 GRAY | ORAL | TABLET, EXTENDED RELEASE | NA | 5.6mg | |||
| OPADRY II Y-30-18037 WHITE | ORAL | TABLET | RX96DK7VVX | 38mg | |||
| OPADRY II Y-30-18037 WHITE | ORAL | TABLET, EXTENDED RELEASE | RX96DK7VVX | 33mg | |||
| OPADRY II Y-30-18037 WHITE | ORAL | TABLET, FILM COATED | RX96DK7VVX | 86mg | |||
| OPADRY II Y-30-18037 WHITE | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | RX96DK7VVX | 26mg | |||
| OPADRY II YS-30-17265A BEIGE | ORAL | TABLET | NA | 6mg | |||
| OPADRY II YS-30-17265A BEIGE | ORAL | TABLET, EXTENDED RELEASE | NA | 9mg | |||
| OPADRY II YS-30-18105 WHITE | ORAL | TABLET | NA | 108mg | |||
| OPADRY II YS-30-18105 WHITE | ORAL | TABLET, EXTENDED RELEASE | NA | 144mg | |||
| OPADRY OY-54937 PINK | ORAL | TABLET, FILM COATED | NA | 3mg | |||
| OPADRY OY-7300 WHITE | ORAL | TABLET | NA | 95mg | |||
| OPADRY OY-B-32830 | ORAL | TABLET | NA | 56mg | |||
| OPADRY OY-L-34836 PINK | ORAL | TABLET | NA | 24mg | |||
| OPADRY OY-LS-23016 ORANGE | ORAL | TABLET, FILM COATED | NA | 6mg | |||
| OPADRY OY-LS-23018 ORANGE | ORAL | TABLET, DELAYED RELEASE | NA | 6mg | |||
| OPADRY OY-LS-23018 ORANGE | ORAL | TABLET, EXTENDED RELEASE | NA | 4.5mg | |||
| OPADRY OY-LS-37200 BUFF | ORAL | TABLET | NA | 10mg | |||
| OPADRY OY-LS-37200 BUFF | ORAL | TABLET, FILM COATED | NA | 9mg | |||
| OPADRY OY-S-30913 BLUE | ORAL | TABLET | NA | 30mg | |||
| OPADRY OY-S-30913 BLUE | ORAL | TABLET, COATED | NA | 13mg | |||
| OPADRY OY-S-30913 BLUE | ORAL | TABLET, FILM COATED | NA | 106mg | |||
| OPADRY OY-S-32921 YELLOW | ORAL | TABLET | NA | 4mg | |||
| OPADRY OY-S-32921 YELLOW | ORAL | TABLET, FILM COATED | NA | 4mg | |||
| OPADRY OY-S-33016 ORANGE | ORAL | TABLET | NA | 90mg | |||
| OPADRY OY-S-33016 ORANGE | ORAL | TABLET, COATED | NA | 3.3mg | |||
| OPADRY OY-S-38956 WHITE | ORAL | TABLET | NA | 24mg | |||
| OPADRY OY-S-7322 WHITE | ORAL | TABLET | NA | 34mg | |||
| OPADRY OY-S-7322 WHITE | ORAL | TABLET, FILM COATED | NA | 9mg | |||
| OPADRY OY-S-7399 WHITE | ORAL | TABLET | NA | 19mg | |||
| OPADRY OY-S-7399 WHITE | ORAL | TABLET, FILM COATED | NA | 10mg | |||
| OPADRY OY-SR-34907 | ORAL | TABLET | NA | 25mg | |||
| OPADRY Y-1-3211 GREEN | ORAL | TABLET | NA | NA | |||
| OPADRY Y-1-3211 GREEN | ORAL | TABLET, EXTENDED RELEASE | NA | NA | |||
| OPADRY Y-1-4234 BLUE | ORAL | TABLET | NA | 3.06mg | |||
| OPADRY Y-1-7503 GRAY | ORAL | TABLET, EXTENDED RELEASE | NA | 5mg | |||
| OPADRY Y-30-14565 PINK | ORAL | TABLET, FILM COATED | NA | 144mg | |||
| OPADRY Y-30-17267 BEIGE | ORAL | TABLET | NA | NA | |||
| OPADRY Y-30-17267 BEIGE | ORAL | TABLET, FILM COATED | NA | NA | |||
| OPADRY Y-5-2394 ORANGE | ORAL | TABLET | NA | 31.5mg | |||
| OPADRY YS-1-003 WHITE | ORAL | TABLET | NA | 24mg | |||
| OPADRY YS-1-12732 YELLOW | ORAL | TABLET, FILM COATED | NA | 20.96mg | |||
| OPADRY YS-1-13065A ORANGE | ORAL | TABLET | NA | 41mg | |||
| OPADRY YS-1-13148A ORANGE | ORAL | TABLET | NA | 10mg | |||
| OPADRY YS-1-13148A ORANGE | ORAL | TABLET, FILM COATED | NA | 5mg | |||
| OPADRY YS-1-13271 ORANGE | ORAL | TABLET, FILM COATED | NA | 20mg | |||
| OPADRY YS-1-14130 PINK | ORAL | TABLET | NA | 12mg | |||
| OPADRY YS-1-14130 PINK | ORAL | TABLET, COATED | NA | 5mg | |||
| OPADRY YS-1-1543 PINK | ORAL | TABLET | NA | 6mg | |||
| OPADRY YS-1-1543 PINK | ORAL | TABLET, EXTENDED RELEASE | NA | 36mg | |||
| OPADRY YS-1-1543 PINK | ORAL | TABLET, FILM COATED | NA | 4.8mg | |||
| OPADRY YS-1-17307A BUTTERSCOTCH | ORAL | TABLET | NA | 6mg | |||
| OPADRY YS-1-17307A BUTTERSCOTCH | ORAL | TABLET, FILM COATED | NA | 5mg | |||
| OPADRY YS-1-2013 YELLOW | ORAL | TABLET | NA | 8.19mg | |||
| OPADRY YS-1-2134 YELLOW | ORAL | TABLET | NA | 147.8mg | |||
| OPADRY YS-1-2398 ORANGE | ORAL | TABLET | NA | 25.3mg | |||
| OPADRY YS-1-2534 | ORAL | TABLET | NA | 147.8mg | |||
| OPADRY YS-1-2534 | ORAL | TABLET, FILM COATED | NA | 20mg | |||
| OPADRY YS-1-2563 ORANGE | ORAL | TABLET | NA | 11.25mg | |||
| OPADRY YS-1-2623 BROWN | ORAL | TABLET, FILM COATED | NA | 34mg | |||
| OPADRY YS-1-3105 GREEN | ORAL | TABLET | NA | 15mg | |||
| OPADRY YS-1-3130 GREEN | ORAL | TABLET | NA | 36mg | |||
| OPADRY YS-1-3130 GREEN | ORAL | TABLET, COATED | NA | 20mg | |||
| OPADRY YS-1-3130 GREEN | ORAL | TABLET, EXTENDED RELEASE | NA | 8.08mg | |||
| OPADRY YS-1-3166 GREEN | ORAL | TABLET | NA | 12mg | |||
| OPADRY YS-1-4235 BLUE | ORAL | TABLET | NA | 20.25mg | |||
| OPADRY YS-1-4236 BLUE | ORAL | TABLET | NA | 4.4mg | |||
| OPADRY YS-1-4236 BLUE | ORAL | TABLET, EXTENDED RELEASE | NA | 5mg | |||
| OPADRY YS-1-4236 BLUE | ORAL | TABLET, FILM COATED | NA | 12.5mg | |||
| OPADRY YS-1-6378G YELLOW | ORAL | TABLET | NA | 13.4mg | |||
| OPADRY YS-1-6382G YELLOW | ORAL | TABLET | NA | 88mg | |||
| OPADRY YS-1-6382G YELLOW | ORAL | TABLET, COATED | NA | 6mg | |||
| OPADRY YS-1-7003 WHITE | ORAL | CAPSULE | NA | 7mg | |||
| OPADRY YS-1-7003 WHITE | ORAL | CAPSULE, DELAYED RELEASE | NA | 10mg | |||
| OPADRY YS-1-7003 WHITE | ORAL | CAPSULE, EXTENDED RELEASE | NA | 19mg | |||
| OPADRY YS-1-7003 WHITE | ORAL | TABLET | NA | 403mg | |||
| OPADRY YS-1-7003 WHITE | ORAL | TABLET, COATED | NA | 14mg | |||
| OPADRY YS-1-7003 WHITE | ORAL | TABLET, DELAYED RELEASE | NA | 17mg | |||
| OPADRY YS-1-7003 WHITE | ORAL | TABLET, EXTENDED RELEASE | NA | 100mg | |||
| OPADRY YS-1-7003 WHITE | ORAL | TABLET, FILM COATED | NA | 36mg | |||
| OPADRY YS-1-7003 WHITE | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | NA | 6.24mg | |||
| OPADRY YS-1-7003H WHITE | ORAL | TABLET | NA | 5mg | |||
| OPADRY YS-1-7003H WHITE | ORAL | TABLET, FILM COATED | NA | 4mg | |||
| OPADRY YS-1-8325 BEIGE | ORAL | TABLET | NA | 16mg | |||
| OPADRY YS-2-7013 CLEAR | ORAL | TABLET | NA | 4.44mg | |||
| OPADRY YS-2-7013 CLEAR | ORAL | TABLET, COATED | NA | 2.7mg | |||
| OPADRY YS-2-7013 CLEAR | ORAL | TABLET, FILM COATED | NA | 1.2mg | |||
| OPADRY YS-2-7063 WHITE | ORAL | TABLET, EXTENDED RELEASE | NA | 48mg | |||
| OPADRY YS-3-7011 CLEAR | ORAL | TABLET | NA | 18mg | |||
| OPADRY YS-3-7011 CLEAR | ORAL | TABLET, FILM COATED | NA | 5.25mg | |||
| OPADRY YS-3-7031 CLEAR | ORAL | TABLET | NA | 69mg | |||
| OPADRY YS-3-7413 CLEAR | ORAL | TABLET | NA | 4mg | |||
| OPADRY YS-3-7413 CLEAR | ORAL | TABLET, COATED | NA | 2.4mg | |||
| OPADRY YS-3-7413 CLEAR | ORAL | TABLET, EXTENDED RELEASE | NA | 40mg | |||
| OPADRY YS-3-7413 CLEAR | ORAL | TABLET, FILM COATED | NA | 1.5mg | |||
| OPADRY YS-5-2370 ORANGE | ORAL | TABLET | NA | NA | |||
| OPADRY YS-5-2370 ORANGE | ORAL | TABLET, FILM COATED | NA | NA | |||
| OPAGLOS GS 2-0300 | ORAL | TABLET, COATED | NA | NA | |||
| OPAGLOS GS 2-0310 | ORAL | TABLET | NA | 3.5mg | |||
| OPAGLOS GS 2-0310 | ORAL | TABLET, COATED | NA | 0.76mg | |||
| OPALUX AS 2236 | ORAL | TABLET | NA | 15.75mg | |||
| OPALUX AS 2236 | ORAL | TABLET, COATED | NA | 22.13mg | |||
| OPALUX AS 2236 | ORAL | TABLET, DELAYED RELEASE | NA | NA | |||
| OPALUX AS 2236 | ORAL | TABLET, EXTENDED RELEASE | NA | 11.8mg | |||
| OPALUX AS 2413 | ORAL | TABLET, COATED | NA | NA | |||
| OPALUX AS 3389 GREEN | ORAL | TABLET | NA | NA | |||
| OPALUX AS 3391 GREEN | ORAL | TABLET | NA | 0.2mg | |||
| OPALUX AS 3391 GREEN | ORAL | TABLET, COATED | NA | 1.18mg | |||
| OPALUX AS 7535 GRAY | ORAL | TABLET, COATED | NA | NA | |||
| OPASPRAY K-1-1230 PINK | ORAL | TABLET | NA | NA | |||
| OPASPRAY K-1-1437 | ORAL | TABLET | NA | NA | |||
| OPASPRAY K-1-1573 LAVENDER | ORAL | TABLET | NA | 12mg | |||
| OPASPRAY K-1-2013 YELLOW | ORAL | TABLET | NA | 8mg | |||
| OPASPRAY K-1-2301 PEACH | ORAL | TABLET | NA | 4.7mg | |||
| OPASPRAY K-1-2303 ORANGE | ORAL | TABLET | NA | 0.35mg | |||
| OPASPRAY K-1-2304 ORANGE | ORAL | TABLET | NA | 1.8mg | |||
| OPASPRAY K-1-2314 ORANGE | ORAL | TABLET | NA | 3.74mg | |||
| OPASPRAY K-1-2327 ORANGE | ORAL | TABLET, EXTENDED RELEASE | NA | 6mg | |||
| OPASPRAY K-1-2430 | ORAL | TABLET | NA | 13.5mg | |||
| OPASPRAY K-1-2473 | ORAL | TABLET | NA | 22.5mg | |||
| OPASPRAY K-1-2473 | ORAL | TABLET, FILM COATED | NA | 2.5mg | |||
| OPASPRAY K-1-3000 | ORAL | TABLET | NA | 0.6mg | |||
| OPASPRAY K-1-3000 | ORAL | TABLET, COATED | NA | 0.6mg | |||
| OPASPRAY K-1-3142 GREEN | ORAL | TABLET, EXTENDED RELEASE | NA | 5.1mg | |||
| OPASPRAY K-1-3147 | ORAL | TABLET | NA | 3mg | |||
| OPASPRAY K-1-3147 | ORAL | TABLET, EXTENDED RELEASE | NA | 2mg | |||
| OPASPRAY K-1-3147 | ORAL | TABLET, FILM COATED | NA | 0.6mg | |||
| OPASPRAY K-1-3148 GREEN | ORAL | TABLET | NA | 1.35mg | |||
| OPASPRAY K-1-3148 GREEN | ORAL | TABLET, FILM COATED | NA | 0.74mg | |||
| OPASPRAY K-1-3178 GREEN | ORAL | TABLET | NA | 1.6mg | |||
| OPASPRAY K-1-3220 GREEN | ORAL | TABLET | NA | 1.8mg | |||
| OPASPRAY K-1-3220 GREEN | ORAL | TABLET, FILM COATED | NA | 0.7mg | |||
| OPASPRAY K-1-3300-C GREEN | ORAL | TABLET | NA | 2.1mg | |||
| OPASPRAY K-1-4136 BLUE | ORAL | TABLET | NA | NA | |||
| OPASPRAY K-1-4136 BLUE | ORAL | TABLET, COATED | NA | 0.6mg | |||
| OPASPRAY K-1-4136 BLUE | ORAL | TABLET, FILM COATED | NA | 3mg | |||
| OPASPRAY K-1-4234 BLUE | ORAL | TABLET | NA | 1.53mg | |||
| OPASPRAY K-1-4731 PURPLE | ORAL | TABLET | NA | 0.5mg | |||
| OPASPRAY K-1-4743 LAVENDER | ORAL | TABLET | NA | 2.2mg | |||
| OPASPRAY K-1-9039-L BROWN | ORAL | TABLET | NA | 12.2mg | |||
| OPASPRAY K-1-9039-L BROWN | ORAL | TABLET, FILM COATED | NA | 4.65mg | |||
| OPASPRAY M-1-3459 B ORANGE | ORAL | TABLET | NA | 4mg | |||
| PARFUM CREME 45/3 | TOPICAL | GEL | NA | 0.1%w/w | |||
| PEG 6-32 STEARATE/GLYCOL STEARATE | TOPICAL | CREAM | NA | 19.6%w/w | |||
| PEG 6-32 STEARATE/GLYCOL STEARATE | VAGINAL | CREAM | NA | 19.6%w/w | |||
| PEG/PPG-4/30 COPOLYMER | OPHTHALMIC | SOLUTION | 6SG11EPD3Z | NA | |||
| POLOXAMER 331 | ORAL | POWDER, FOR SOLUTION | 691397134 | IS93EQR73R | 1000mg/5ml | ||
| POLOXAMER 331 | ORAL | POWDER, FOR SUSPENSION | 691397134 | IS93EQR73R | 26.43mg/5ml | ||
| POLOXAMER 331 | ORAL | SUSPENSION | 691397134 | IS93EQR73R | 12.5mg/5ml | ||
| POLY(METHYL ACRYLATE-CO-METHYL METHACRYLATE-CO-METHACRYLIC ACID 7:3:1; 280000 MW) | ORAL | CAPSULE, EXTENDED RELEASE | 26936243 | 99Q3C7L77T | 88mg | ||
| POLYETHYLENE GLYCOL 300 | AURICULAR (OTIC) | DROPS | 25322683 | 5655G9Y8AQ | 97.43%w/w | ||
| POLYETHYLENE GLYCOL 300 | INTRAMUSCULAR | INJECTION | 25322683 | 5655G9Y8AQ | 50%v/v | ||
| POLYETHYLENE GLYCOL 300 | INTRAMUSCULAR | SOLUTION | 25322683 | 5655G9Y8AQ | 16920mg | ||
| POLYETHYLENE GLYCOL 300 | INTRAVENOUS | INJECTION | 25322683 | 5655G9Y8AQ | 2768mg | ||
| POLYETHYLENE GLYCOL 300 | INTRAVENOUS | INJECTION, SOLUTION, CONCENTRATE | 25322683 | 5655G9Y8AQ | 44.22%w/v | ||
| POLYETHYLENE GLYCOL 300 | INTRAVENOUS | LIQUID | 25322683 | 5655G9Y8AQ | 5850mg | ||
| POLYETHYLENE GLYCOL 300 | INTRAVENOUS | SOLUTION | 25322683 | 5655G9Y8AQ | 16920mg | ||
| POLYETHYLENE GLYCOL 300 | OPHTHALMIC | OINTMENT | 25322683 | 5655G9Y8AQ | NA | ||
| POLYETHYLENE GLYCOL 300 | ORAL | TABLET | 25322683 | 5655G9Y8AQ | 1mg | ||
| POLYETHYLENE GLYCOL 300 | ORAL | TABLET, FILM COATED | 25322683 | 5655G9Y8AQ | 2mg | ||
| POLYETHYLENE GLYCOL 300 | TOPICAL | CREAM | 25322683 | 5655G9Y8AQ | 4%w/w | ||
| POLYETHYLENE GLYCOL 300 | TOPICAL | OINTMENT | 25322683 | 5655G9Y8AQ | 1114mg | ||
| POLYETHYLENE GLYCOL 300 | TOPICAL | SOLUTION | 25322683 | 5655G9Y8AQ | 29.7%w/w | ||
| POLYETHYLENE GLYCOL 3000 | ORAL | TABLET | 25322683 | SA1B764746 | 8mg | ||
| POLYETHYLENE GLYCOL 3000 | ORAL | TABLET, EXTENDED RELEASE | 25322683 | SA1B764746 | 24mg | ||
| POLYETHYLENE GLYCOL 3350 | INTRA-ARTICULAR | INJECTION | 25322683 | G2M7P15E5P | 56mg | ||
| POLYETHYLENE GLYCOL 3350 | INTRA-ARTICULAR | INJECTION, SUSPENSION | 25322683 | G2M7P15E5P | 56mg | ||
| POLYETHYLENE GLYCOL 3350 | INTRALESIONAL | INJECTION, SUSPENSION | 25322683 | G2M7P15E5P | 56mg | ||
| POLYETHYLENE GLYCOL 3350 | INTRAMUSCULAR | INJECTION | 25322683 | G2M7P15E5P | 56mg | ||
| POLYETHYLENE GLYCOL 3350 | INTRAMUSCULAR | INJECTION, SUSPENSION | 25322683 | G2M7P15E5P | 56mg | ||
| POLYETHYLENE GLYCOL 3350 | INTRAMUSCULAR | INJECTION, SUSPENSION, EXTENDED RELEASE | 25322683 | G2M7P15E5P | 60mg | ||
| POLYETHYLENE GLYCOL 3350 | INTRASYNOVIAL | INJECTION | 25322683 | G2M7P15E5P | 3%w/v | ||
| POLYETHYLENE GLYCOL 3350 | INTRASYNOVIAL | INJECTION, SUSPENSION | 25322683 | G2M7P15E5P | 56mg | Y | |
| POLYETHYLENE GLYCOL 3350 | INTRAVENOUS | INJECTION | 25322683 | G2M7P15E5P | 0.5ml | ||
| POLYETHYLENE GLYCOL 3350 | NASAL | SOLUTION | 25322683 | G2M7P15E5P | 40000mg/100ml | ||
| POLYETHYLENE GLYCOL 3350 | ORAL | CAPSULE | 25322683 | G2M7P15E5P | 576mg | ||
| POLYETHYLENE GLYCOL 3350 | ORAL | CAPSULE, EXTENDED RELEASE | 25322683 | G2M7P15E5P | 51mg | ||
| POLYETHYLENE GLYCOL 3350 | ORAL | SUSPENSION | 25322683 | G2M7P15E5P | 45mg/1ml | ||
| POLYETHYLENE GLYCOL 3350 | ORAL | SUSPENSION, EXTENDED RELEASE | 25322683 | G2M7P15E5P | 37mg | ||
| POLYETHYLENE GLYCOL 3350 | ORAL | TABLET | 25322683 | G2M7P15E5P | 52mg | ||
| POLYETHYLENE GLYCOL 3350 | ORAL | TABLET, CHEWABLE | 25322683 | G2M7P15E5P | 15mg | ||
| POLYETHYLENE GLYCOL 3350 | ORAL | TABLET, COATED | 25322683 | G2M7P15E5P | 0.5mg | ||
| POLYETHYLENE GLYCOL 3350 | ORAL | TABLET, DELAYED RELEASE | 25322683 | G2M7P15E5P | 18mg | ||
| POLYETHYLENE GLYCOL 3350 | ORAL | TABLET, EXTENDED RELEASE | 25322683 | G2M7P15E5P | 61mg | ||
| POLYETHYLENE GLYCOL 3350 | ORAL | TABLET, FILM COATED | 25322683 | G2M7P15E5P | 20mg | ||
| POLYETHYLENE GLYCOL 3350 | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 25322683 | G2M7P15E5P | 8.5mg | ||
| POLYETHYLENE GLYCOL 3350 | ORAL | TABLET, ORALLY DISINTEGRATING | 25322683 | G2M7P15E5P | 0.09mg | ||
| POLYETHYLENE GLYCOL 3350 | RECTAL | SUPPOSITORY | 25322683 | G2M7P15E5P | 1425.96mg | ||
| POLYETHYLENE GLYCOL 3350 | SOFT TISSUE | INJECTION, SUSPENSION | 25322683 | G2M7P15E5P | 56mg | ||
| POLYETHYLENE GLYCOL 3350 | SUBCUTANEOUS | INJECTION, SUSPENSION | 25322683 | G2M7P15E5P | 2.88%w/v | ||
| POLYETHYLENE GLYCOL 3350 | SUBCUTANEOUS | SUSPENSION | 25322683 | G2M7P15E5P | 2.88%w/v | ||
| POLYETHYLENE GLYCOL 3350 | TOPICAL | CREAM | 25322683 | G2M7P15E5P | 396mg | ||
| POLYETHYLENE GLYCOL 3350 | TOPICAL | OINTMENT | 25322683 | G2M7P15E5P | 990mg | ||
| POLYETHYLENE GLYCOL 3350 | VAGINAL | SUPPOSITORY | 25322683 | G2M7P15E5P | NA | ||
| POLYETHYLENE GLYCOL 3500 | ORAL | TABLET | 25322683 | FVS1AZD90Y | 3.05mg | ||
| POLYETHYLENE GLYCOL MONOMETHYL ETHER 350 | TOPICAL | GEL | 9004744 | ENK4Y6S66X | 400mg | ||
| POLYGLYCERYL-3 OLEATE | ORAL | CAPSULE | 33940986 | XRQ165498B | 2mg | ||
| POLYGLYCERYL-3 OLEATE | ORAL | CAPSULE, GELATIN COATED | 33940986 | XRQ165498B | 1mg | ||
| POLYGLYCERYL-3 OLEATE | ORAL | SOLUTION | 33940986 | XRQ165498B | 310mg/1ml | ||
| POLYGLYCERYL-3 OLEATE | TOPICAL | CREAM | 33940986 | XRQ165498B | 2.7%w/w | ||
| POLYGLYCERYL-3 OLEATE | VAGINAL | CREAM | 33940986 | XRQ165498B | 2.7%w/w | ||
| POLYOXYL 35 CASTOR OIL | INTRAMUSCULAR | INJECTION, EMULSION | 61791126 | 6D4M1DAL6O | 1750mg | ||
| POLYOXYL 35 CASTOR OIL | INTRAVENOUS | INJECTION | 61791126 | 6D4M1DAL6O | 27668mg | ||
| POLYOXYL 35 CASTOR OIL | INTRAVENOUS | INJECTION, EMULSION | 61791126 | 6D4M1DAL6O | 350mg | ||
| POLYOXYL 35 CASTOR OIL | INTRAVENOUS | INJECTION, SOLUTION | 61791126 | 6D4M1DAL6O | 52.75%w/v | ||
| POLYOXYL 35 CASTOR OIL | INTRAVESICAL | SOLUTION | 61791126 | 6D4M1DAL6O | 10588mg | ||
| POLYOXYL 35 CASTOR OIL | OPHTHALMIC | SOLUTION | 61791126 | 6D4M1DAL6O | 5%w/v | ||
| POLYOXYL 35 CASTOR OIL | OPHTHALMIC | SOLUTION/ DROPS | 61791126 | 6D4M1DAL6O | 5%w/v | ||
| POLYOXYL 35 CASTOR OIL | ORAL | CAPSULE | 61791126 | 6D4M1DAL6O | 1170mg | ||
| POLYOXYL 35 CASTOR OIL | ORAL | SOLUTION | 61791126 | 6D4M1DAL6O | 515mg/1ml | ||
| POLYOXYL 35 CASTOR OIL | ORAL | SUSPENSION | 61791126 | 6D4M1DAL6O | 0.4mg/1ml | ||
| POLYOXYL 35 CASTOR OIL | ORAL | TABLET | 61791126 | 6D4M1DAL6O | 4mg | ||
| POLYOXYL 35 CASTOR OIL | ORAL | TABLET, EXTENDED RELEASE | 61791126 | 6D4M1DAL6O | 5.2mg | ||
| POLYOXYL 35 CASTOR OIL | SUBCUTANEOUS | INJECTION, EMULSION | 61791126 | 6D4M1DAL6O | 1750mg | ||
| POLYOXYL 35 CASTOR OIL | SUBLINGUAL | TABLET | 61791126 | 6D4M1DAL6O | 4mg | ||
| POLYOXYL 35 CASTOR OIL | TOPICAL | CREAM | 61791126 | 6D4M1DAL6O | 4%w/w | ||
| POLYOXYL 6 AND POLYOXYL 32 PALMITOSTEARATE | TOPICAL | CREAM | NA | 20%w/w | |||
| POLYOXYL 6 AND POLYOXYL 32 PALMITOSTEARATE | TOPICAL | LOTION | NA | 5%w/w | |||
| POLYQUATERNIUM-7 (70/30 ACRYLAMIDE/DADMAC; 1600000 MW) | TOPICAL | SHAMPOO | 26590056 | 0L414VCS5Y | 1%w/w | ||
| POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER (3:1; 45000 MW) | ORAL | TABLET | 121786161 | 23ZQ42JZZH | 5.37mg | ||
| POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER (3:1; 45000 MW) | ORAL | TABLET, EXTENDED RELEASE | 121786161 | 23ZQ42JZZH | 76mg | ||
| POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER (3:1; 45000 MW) | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 121786161 | 23ZQ42JZZH | 7mg | ||
| POVIDONE K25/30 | ORAL | TABLET | NA | 138mg | |||
| POVIDONE K30 | BUCCAL | TABLET | 9003398 | U725QWY32X | 1mg | ||
| POVIDONE K30 | INTRAMUSCULAR | INJECTION | 9003398 | U725QWY32X | 0.59%w/v | ||
| POVIDONE K30 | OPHTHALMIC | SOLUTION | 9003398 | U725QWY32X | 42mg | Y | |
| POVIDONE K30 | OPHTHALMIC | SOLUTION/ DROPS | 9003398 | U725QWY32X | 4mg | ||
| POVIDONE K30 | OPHTHALMIC | SUSPENSION | 9003398 | U725QWY32X | 0.6%w/v | ||
| POVIDONE K30 | ORAL | CAPSULE | 9003398 | U725QWY32X | 160mg | ||
| POVIDONE K30 | ORAL | CAPSULE, COATED, EXTENDED RELEASE | 9003398 | U725QWY32X | 15mg | ||
| POVIDONE K30 | ORAL | CAPSULE, DELAYED RELEASE | 9003398 | U725QWY32X | 33mg | ||
| POVIDONE K30 | ORAL | CAPSULE, DELAYED RELEASE PELLETS | 9003398 | U725QWY32X | 178mg | ||
| POVIDONE K30 | ORAL | CAPSULE, EXTENDED RELEASE | 9003398 | U725QWY32X | 120mg | Y | |
| POVIDONE K30 | ORAL | CAPSULE, GELATIN COATED | 9003398 | U725QWY32X | 21mg | ||
| POVIDONE K30 | ORAL | CAPSULE, LIQUID FILLED | 9003398 | U725QWY32X | 101mg | ||
| POVIDONE K30 | ORAL | GRANULE | 9003398 | U725QWY32X | 202mg | ||
| POVIDONE K30 | ORAL | GRANULE, EFFERVESCENT | 9003398 | U725QWY32X | 40mg | ||
| POVIDONE K30 | ORAL | GRANULE, FOR SUSPENSION | 9003398 | U725QWY32X | 120mg | ||
| POVIDONE K30 | ORAL | LIQUID | 9003398 | U725QWY32X | 300mg | ||
| POVIDONE K30 | ORAL | LOZENGE | 9003398 | U725QWY32X | 700mg | ||
| POVIDONE K30 | ORAL | PELLET | 9003398 | U725QWY32X | 24mg | ||
| POVIDONE K30 | ORAL | POWDER | 9003398 | U725QWY32X | 378mg | ||
| POVIDONE K30 | ORAL | POWDER, FOR SOLUTION | 9003398 | U725QWY32X | 150mg | ||
| POVIDONE K30 | ORAL | POWDER, FOR SUSPENSION | 9003398 | U725QWY32X | 70mg | ||
| POVIDONE K30 | ORAL | SOLUTION | 9003398 | U725QWY32X | 150mg | ||
| POVIDONE K30 | ORAL | SUSPENSION | 9003398 | U725QWY32X | 148mg | ||
| POVIDONE K30 | ORAL | SUSPENSION, EXTENDED RELEASE | 9003398 | U725QWY32X | 474mg | ||
| POVIDONE K30 | ORAL | TABLET | 9003398 | U725QWY32X | 2828mg | ||
| POVIDONE K30 | ORAL | TABLET, CHEWABLE | 9003398 | U725QWY32X | 245mg | ||
| POVIDONE K30 | ORAL | TABLET, CHEWABLE, EXTENDED RELEASE | 9003398 | U725QWY32X | 12mg | ||
| POVIDONE K30 | ORAL | TABLET, COATED | 9003398 | U725QWY32X | 160mg | ||
| POVIDONE K30 | ORAL | TABLET, DELAYED RELEASE | 9003398 | U725QWY32X | 516mg | ||
| POVIDONE K30 | ORAL | TABLET, DELAYED RELEASE PARTICLES | 9003398 | U725QWY32X | 70mg | ||
| POVIDONE K30 | ORAL | TABLET, EXTENDED RELEASE | 9003398 | U725QWY32X | 230mg | ||
| POVIDONE K30 | ORAL | TABLET, FILM COATED | 9003398 | U725QWY32X | 245mg | ||
| POVIDONE K30 | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 9003398 | U725QWY32X | 45mg | ||
| POVIDONE K30 | ORAL | TABLET, FOR SUSPENSION | 9003398 | U725QWY32X | 462mg | ||
| POVIDONE K30 | ORAL | TABLET, ORALLY DISINTEGRATING | 9003398 | U725QWY32X | 71mg | ||
| POVIDONE K30 | ORAL | TROCHE | 9003398 | U725QWY32X | 100mg | ||
| POVIDONE K30 | SUBLINGUAL | FILM | 9003398 | U725QWY32X | 7mg | ||
| POVIDONE K30 | SUBLINGUAL | TABLET | 9003398 | U725QWY32X | 30mg | ||
| POVIDONE K30 | TOPICAL | AEROSOL, FOAM | 9003398 | U725QWY32X | 1.9%w/w | ||
| POVIDONE K30 | TOPICAL | SOLUTION | 9003398 | U725QWY32X | 4%w/v | ||
| POVIDONE K30 | TRANSDERMAL | FILM, EXTENDED RELEASE | 9003398 | U725QWY32X | 16mg | ||
| POVIDONE K30 | TRANSDERMAL | SYSTEM | 9003398 | U725QWY32X | 15mg | ||
| POVIDONE K30 | VAGINAL | INSERT | 9003398 | U725QWY32X | 147mg | ||
| SILICONE ADHESIVE 4302 | TRANSDERMAL | SYSTEM | NA | 60mg | |||
| SODIUM LAURETH-3 SULFATE | ORAL | CAPSULE | 13150000 | BPV390UAP0 | 3.5mg | ||
| SODIUM LAURETH-3 SULFATE | ORAL | TABLET | 13150000 | BPV390UAP0 | 0.91mg | ||
| SODIUM LAURETH-3 SULFATE | TOPICAL | CREAM | 13150000 | BPV390UAP0 | NA | ||
| SODIUM LAURETH-3 SULFATE | TOPICAL | SHAMPOO | 13150000 | BPV390UAP0 | 850mg | ||
| SODIUM LAURETH-3 SULFATE | TOPICAL | SPRAY | 13150000 | BPV390UAP0 | 0.1%w/w | ||
| SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE | INTRAVENOUS | INJECTABLE, LIPOSOMAL | 247925286 | 3L6NN8ZZKU | 129mg | ||
| SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE | INTRAVENOUS | INJECTION | 247925286 | 3L6NN8ZZKU | 1mg | ||
| SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE | INTRAVENOUS | INJECTION, SUSPENSION, LIPOSOMAL | 247925286 | 3L6NN8ZZKU | 0.32%w/v | ||
| STEAROYL POLYOXYL-32 GLYCERIDES | ORAL | CAPSULE | 9011216 | G6EP177239 | 960mg | ||
| STEAROYL POLYOXYL-32 GLYCERIDES | ORAL | CAPSULE, EXTENDED RELEASE | 9011216 | G6EP177239 | 8mg | ||
| STEAROYL POLYOXYL-32 GLYCERIDES | ORAL | TABLET | 9011216 | G6EP177239 | 3mg | ||
| TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (35/65 W/W; 50000000 PA.S) | TRANSDERMAL | FILM, EXTENDED RELEASE | 0A6MDS9SLT | 171.17mg | |||
| TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (35/65 W/W; 50000000 PA.S) | TRANSDERMAL | SYSTEM | 0A6MDS9SLT | 45mg | |||
| XYLITOL 300 | ORAL | TABLET, ORALLY DISINTEGRATING | NA | 10mg |
FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly
Data Through: January 5, 2024
Database Last Updated: January 26, 2024